Adaptive immunity and antigen-specific activation in obesity-Associated insulin resistance

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Chng, Melissa Hui Yen ^a   Alonso, Michael N ^a   Barnes, Sarah E ^a   Nguyen, Khoa D ^a   Engleman, Edgar G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; GLUCOSE; T LYMPHOCYTE RECEPTOR; B7 ANTIGEN; CD86 ANTIGEN;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; INSULIN RESISTANCE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MEMORY T LYMPHOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; INSULIN RESISTANCE; OBESITY; T-LYMPHOCYTES;

EID: 84934928555     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/593075     Document Type: Review

References (145)

1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, 6th edition, 2013, http://www.idf .org/diabetesatlas.
2. I. Ioannidis, "The road from obesity to type 2 diabetes, " Angiology, vol. 59, no. 2, supplement, pp. 39S-43S, 2008.
3. J. McNelis and J. Olefsky, "Macrophages, immunity, and metabolic disease, " Immunity, vol. 41, no. 1, pp. 36-48, 2014.
4. M. Y. Donath, "Targeting inflammation in the treatment of type 2 diabetes: time to start, " Nature Reviews Drug Discovery, vol. 13, no. 6, pp. 465-476, 2014.
5. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, "Adipose expression of tumor necrosis factor: direct role in obesity-linked insulin resistance, " Science, vol. 259, no. 5091, pp. 87-91, 1993.
6. V. Z. Rocha, E. J. Folco, G. Sukhova et al., "Interferon, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity, " Circulation Research, vol. 103, no. 5, pp. 467-476, 2008.
7. B. V and anmagsar, Y.-H. Youm, A. Ravussin et al., "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, " Nature Medicine, vol. 17, no. 2, pp. 179-189, 2011.
8. E.-G. Hong, J. K. Hwi, Y.-R. Cho et al., "Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle, " Diabetes, vol. 58, no. 11, pp. 2525-2535, 2009.
9. R. R. Ricardo-Gonzalez, A. R. Eagle, J. I. Odegaard et al., "IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 52, pp. 22617-22622, 2010.
10. M. E. Rausch, S. Weisberg, P. Vardhana, and D. V. Tortoriello, "Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration, " International Journal of Obesity, vol. 32, no. 3, pp. 451-463, 2008.
11. S. Cinti, G. Mitchell, G. Barbatelli et al., "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, " Journal of Lipid Research, vol. 46, no. 11, pp. 2347-2355, 2005.
12. J. Ye, Z. Gao, J. Yin, and Q. He, "Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice, "TheAmerican Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 4, pp. E1118-E1128, 2007.
13. H. Xu, G. T. Barnes, Q. Yang et al., "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, "The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821-1830, 2003.
14. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth et al., "Macrophage-specific PPAR controls alternative activation and improves insulin resistance, " Nature, vol. 447, no. 7148, pp. 1116-1120, 2007.
15. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization, " Journal of Clinical Investigation, vol. 117, no. 1, pp. 175-184, 2007.
16. C. N. Lumeng, J. B. Delproposto, D. J. Westcott, and A. R. Saltiel, "Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes, " Diabetes, vol. 57, no. 12, pp. 3239-3246, 2008.
17. J. Liu, A. Divoux, J. Sun et al., "Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice, " Nature Medicine, vol. 15, no. 8, pp. 940-945, 2009.
18. S. Talukdar, D. Y. Oh, G. B and yopadhyay et al., "Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase, " Nature Medicine, vol. 18, no. 9, pp. 1407-1412, 2012.
19. M. Stefanovic-Racic, X. Yang, M. S. Turner et al., "Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-Associated increases in CD11c+ cells in adipose tissue and liver, " Diabetes, vol. 61, no. 9, pp. 2330-2339, 2012.
20. D. Wu, A. B. Molofsky, H.-E. Liang et al., "Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis, " Science, vol. 332, no. 6026, pp. 243-247, 2011.
21. E. Hams, R. M. Locksley, A. N. J. McKenzie, and P. G. Fallon, "Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice, " Journal of Immunology, vol. 191, no. 11, pp. 5349-5353, 2013.
22. S. Winer, Y. Chan, G. Paltser et al., "Normalization of obesityassociated insulin resistance through immunotherapy, " Nature Medicine, vol. 15, no. 8, pp. 921-929, 2009.
23. S. Nishimura, I. Manabe, M. Nagasaki et al., "CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, " Nature Medicine, vol. 15, no. 8, pp. 914-920, 2009.
24. L. Shen, M.H. Chng, M.N. Alonso, R. Yuan, D.A. Winer, and E. G. Engleman, "B-1a lymphocytes attenuate insulin resistance, " Diabetes, vol. 64, no. 2, pp. 593-603, 2015.
25. J. M. M. den Haan, R. Arens, and M. C. van Zelm, "The activation of the adaptive immune system: cross-Talk between antigen-presenting cells, T cells and B cells, " Immunology Letters, vol. 162, no. 2, pp. 103-112, 2014.
26. L. A. Velloso, D. L. Eizirik, and M. Cnop, "Type 2 diabetes mellitus-An autoimmune disease?" Nature Reviews Endocrinology, vol. 9, no. 12, pp. 750-755, 2013.
27. A. Gastaldelli, Y. Miyazaki, M. Pettiti et al., "Metabolic effects of visceral fat accumulation in type 2 diabetes, " Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 5098-5103, 2002.
28. T. McLaughlin, C. Lamendola, A. Liu, and F. Abbasi, "Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity, " The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 11, pp. E1756-E1760, 2011.
29. S. K. Fried, D. A. Bunkin, and A. S. Greenberg, "Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, " The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 3, pp. 847-850, 1998.
30. J. M. Bruun, A. S. Lihn, S. B. Pedersen, and B. Richelsen, "Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT, " Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2282-2289, 2005.
31. T. McLaughlin, L.-F. Liu, C. Lamendola et al., "T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 12, pp. 2637-2643, 2014.
32. N. Esser, L. LHomme, A. De Roover et al., "Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue, " Diabetologia, vol. 56, no. 11, pp. 2487-2497, 2013.
33. S. Caspar-Bauguil, B. Cousin, A. Galinier et al., "Adipose tissues as an ancestral immune organ: site-specific change in obesity, " FEBS Letters, vol. 579, no. 17, pp. 3487-3492, 2005.
34. M. Feuerer, L. Herrero, D. Cipolletta et al., "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affectmetabolic parameters, " Nature Medicine, vol. 15, no. 8, pp. 930-939, 2009.
35. M. E. McDonnell, L. M. Ganley-Leal, A. Mehta et al., "B lymphocytes in human subcutaneous adipose crown-like structures, " Obesity, vol. 20, no. 7, pp. 1372-1378, 2012.
36. H. Wu, S. Ghosh, X. D. Perrard et al., "T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity, " Circulation, vol. 115, no. 8, pp. 1029-1038, 2007.
37. C. Duffaut, J. Galitzky, M. Lafontan, and A. Bouloumie, "Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity, " Biochemical and Biophysical Research Communications, vol. 384, no. 4, pp. 482-485, 2009.
38. D. B. Ballak, R. Stienstra, A. Hijmans, L. A. B. Joosten, M. G. Netea, and C. J. Tack, "Combined B-And T-cell deficiency does not protect against obesity-induced glucose intolerance and inflammation, " Cytokine, vol. 62, no. 1, pp. 96-103, 2013.
39. I. M. Khan, X.-Y. Dai Perrard, J. L. Perrard et al., "Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency, " Atherosclerosis, vol. 233, no. 2, pp. 419-428, 2014.
40. D. A. Winer, S. Winer, L. Shen et al., "B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies, " Nature Medicine, vol. 17, no. 5, pp. 610-617, 2011.
41. D. Kägi, B. Ledermann, K. Bürki et al., "Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforindeficient mice, " Nature, vol. 369, no. 6475, pp. 31-37, 1994.
42. J.W. Heusel, R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley, "Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells, " Cell, vol. 76, no. 6, pp. 977-987, 1994.
43. E. Jiang, X. D. Perrard, D. Yang et al., "Essential role of CD11a in CD8+ T-cell accumulation and activation in adipose tissue, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 1, pp. 34-43, 2014.
44. H. Yang, Y.-H. Youm, B.Vandanmagsar et al., "Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance, " Journal of Immunology, vol. 185, no. 3, pp. 1836-1845, 2010.
45. X. S. Revelo, S. Tsai, H. Lei et al., "Perforin is a novel immune regulator of obesity-related insulin resistance, " Diabetes, vol. 64, no. 1, pp. 90-103, 2015.
46. T. Pecht, A. Gutman-Tirosh, N. Bashan, and A. Rudich, "Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans, " Obesity Reviews, vol. 15, no. 4, pp. 322-337, 2014.
47. L. A. Lynch, J. M. OConnell, A. K. Kwasnik, T. J. Cawood, C. OFarrelly, and D. B. OShea, "Are natural killer cells protecting the metabolically healthy obese patient?" Obesity, vol. 17, no. 3, pp. 601-605, 2009.
48. R. L. Travers, A. C. Motta, J. A. Betts, A. Bouloumie, and D. Thompson, "The impact of adiposity on adipose tissue-resident lymphocyte activation in humans, " International Journal of Obesity, vol. 39, no. 5, pp. 762-769, 2014.
49. B. C. Ip, A. E. Hogan, and B. S. Nikolajczyk, "Lymphocyte roles in metabolic dysfunction: of men and mice, " Trends in Endocrinology and Metabolism, vol. 26, no. 2, pp. 91-100, 2015.
50. I. Raphael, S. Nalawade, T. N. Eagar, and T. G. Forsthuber, "T cell subsets and their signature cytokines in autoimmune and inflammatory diseases, " Cytokine, 2014.
51. F. C. McGillicuddy, E. H. Chiquoine, C. C. Hinkle et al., "Interferon attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway, " The Journal of Biological Chemistry, vol. 284, no. 46, pp. 31936-31944, 2009.
52. U. Kintscher, M. Hartge, K. Hess et al., "T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304-1310, 2008.
53. K. J. Strissel, J. DeFuria, M. E. Shaul, G. Bennett, A. S. Greenberg, and M. S. Obin, "T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice, " Obesity, vol. 18, no. 10, pp. 1918-1925, 2010.
54. N. Wong, B. C. Fam, G. R. Cempako et al., "Deficiency in interferon-results in reduced body weight and better glucose tolerance in mice, " Endocrinology, vol. 152, no. 10, pp. 3690-3699, 2011.
55. R. W. ORourke, A. E. White, M. D. Metcalf et al., "Systemic inflammation and insulin sensitivity in obese IFN-knockout mice, " Metabolism: Clinical and Experimental, vol. 61, no. 8, pp. 1152-1161, 2012.
56. Vanderweerd K., W. A. Dik, B. Schrijver et al., "Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg-And Th2-dominated phenotype, " Diabetes, vol. 61, no. 2, pp. 401-408, 2012.
57. A. Viardot, L. K. Heilbronn, D. Samocha-Bonet, F. Mackay, L. V. Campbell, and K. Samaras, "Obesity is associated with activated and insulin resistant immune cells, " Diabetes/Metabolism Research and Reviews, vol. 28, no. 5, pp. 447-454, 2012.
58. L. Pacifico, L. Di Renzo, C. Anania et al., "Increased T-helper interferon secreting cells in obese children, " European Journal of Endocrinology, vol. 154, no. 5, pp. 691-697, 2006.
59. R. Zhao, D. Tang, S. Yi et al., "Elevated peripheral frequencies of th22 cells: a novel potent participant in obesity and type 2 diabetes, " PLoS ONE, vol. 9, no. 1, Article ID e85770, 2014.
60. C. Zeng, X. Shi, B. Zhang et al., "The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications, " Journal of Molecular Medicine, vol. 90, no. 2, pp. 175-186, 2012.
61. D. L. Morris, K.W. Cho, J. L. DelProposto et al., "Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice, " Diabetes, vol. 62, no. 8, pp. 2762-2772, 2013.
62. T. Deng, C. J. Lyon, L. J. Minze et al., "Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation, " Cell Metabolism, vol. 17, no. 3, pp. 411-422, 2013.
63. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, " The Journal of Experimental Medicine, vol. 201, no. 2, pp. 233-240, 2005.
64. M. Jagannathan-Bogdan, M. E. McDonnell, H. Shin et al., "Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes, " The Journal of Immunology, vol. 186, no. 2, pp. 1162-1172, 2011.
65. E. Fabbrini, M. Cella, S. A. McCartney et al., "Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals, " Gastroenterology, vol. 145, no. 2, pp. 366.e3-374.e3, 2013.
66. S. Winer, G. Paltser, Y. Chan et al., "Obesity predisposes toTh17 bias, " European Journal of Immunology, vol. 39, no. 9, pp. 2629-2635, 2009.
67. Y. Chen, J. Tian, X. Tian et al., "Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells, " PLoS ONE, vol. 9, no. 3, Article ID e92450, 2014.
68. A. Bertola, T. Ciucci, D. Rousseau et al., "Identification of adipose tissue dendritic cells correlated with obesity-Associated insulin-resistance and inducing Th17 responses in mice and patients, " Diabetes, vol. 61, no. 9, pp. 2238-2247, 2012.
69. L. A. Zuniga, W. J. Shen, B. Joyce-Shaikh et al., "IL-17 regulates adipogenesis, glucose homeostasis, and obesity, " The Journal of Immunology, vol. 185, no. 11, pp. 6947-6959, 2010.
70. M. Ahmed and S. L. Gaffen, "IL-17 inhibits adipogenesis in part via C/EBP, PPAR and Krüppel-like factors, " Cytokine, vol. 61, no. 3, pp. 898-905, 2013.
71. D. Cipolletta, P. Cohen, B. M. Spiegelman, C. Benoist, and D. Mathis, "Appearance and disappearance of themRNA signature characteristic of T cells in visceral adipose tissue: age, diet, and PPAR effects, " Proceedings of the National Academy of Sciences, vol. 112, no. 2, pp. 482-487, 2015.
72. S. J. Priceman, M. Kujawski, S. Shen et al., "Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 32, pp. 13079-13084, 2013.
73. M. Zeyda, J. Huber, G. Prager, and T. M. Stulnig, "Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients, " Obesity, vol. 19, no. 4, pp. 743-748, 2011.
74. K. Eller, A. Kirsch, A. M. Wolf et al., "Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy, " Diabetes, vol. 60, no. 11, pp. 2954-2962, 2011.
75. J. Deiuliis, Z. Shah, N. Shah et al., "Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers, " PLoS ONE, vol. 6, no. 1, Article ID e16376, 2011.
76. M. M. Tiemessen, A. L. Jagger, H. G. Evans, M. J. C. Van Herwijnen, S. John, and L. S. Taams, "CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 49, pp. 19446-19451, 2007.
77. Y. Ilan, R. Maron, A.-M. Tukpah et al., "Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 21, pp. 9765-9770, 2010.
78. D. Cipolletta, M. Feuerer, A. Li et al., "PPAR is a major driver of the accumulation and phenotype of adipose tissue T reg cells, " Nature, vol. 486, no. 7404, pp. 549-553, 2012.
79. W.-P. Zheng and R. A. Flavell, "The transcription factor GATA-3 is necessary and sufficient forTh2 cytokine gene expression in CD4 T cells, " Cell, vol. 89, no. 4, pp. 587-596, 1997.
80. K. Kang, S. M. Reilly, V. Karabacak et al., "Adipocyte-derived Th2 cytokines and myeloid PPARd regulate macrophage polarization and insulin sensitivity, " CellMetabolism, vol. 7, no. 6, pp. 485-495, 2008.
81. N. Baumgarth, "The double life of a B-1 cell: self-reactivity selects for protective effector functions, " Nature Reviews Immunology, vol. 11, no. 1, pp. 34-46, 2011.
82. K. Hayakawa, R. R. Hardy, L. A. Herzenberg, and L. A. Herzenberg, "Progenitors for Ly-1 B cells are distinct from progenitors for other B cells, " Journal of ExperimentalMedicine, vol. 161, no. 6, pp. 1554-1568, 1985.
83. N. Baumgarth, O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg, "Innate and acquired humoral immunities to influenza virus aremediated by distinct arms of the immune system, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2250-2255, 1999.
84. K. R. Alugupalli, J. M. Leong, R. T. Woodl and , M. Muramatsu, T. Honjo, and R. M. Gerstein, "B1b lymphocytes confer T cellindependent long-lasting immunity, " Immunity, vol. 21, no. 3, pp. 379-390, 2004.
85. R. Madan, F. Demircik, S. Surianarayanan et al., "Nonredundant roles for B cell-derived IL-10 in immune counter-regulation, " The Journal of Immunology, vol. 183, no. 4, pp. 2312-2320, 2009.
86. J. DeFuria, A. C. Belkina, M. Jagannathan-Bogdan et al., "B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 13, pp. 5133-5138, 2013.
87. Q. Wang, X. Zhai, X. Chen, J. Lu, Y. Zhang, and Q. Huang, "Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus, " APMIS, vol. 123, no. 2, pp. 146-151, 2015.
88. S. Nishimura, I. Manabe, S. Takaki et al., "Adipose natural regulatory B cells negatively control adipose tissue inflammation, " Cell Metabolism, vol. 18, no. 5, pp. 759-766, 2013.
89. D. F. Barbeiro, H. V. Barbeiro, J. Faintuch et al., "B-1 cells temper endotoxemic inflammatory responses, " Immunobiology, vol. 216, no. 3, pp. 302-308, 2011.
90. S.-C. Wong, A.-L. Puaux, M. Chittezhath et al., "Macrophage polarization to a unique phenotype driven by B cells, " European Journal of Immunology, vol. 40, no. 8, pp. 2296-2307, 2010.
91. L. Wu, V. V. Parekh, J. Hsiao, D. Kitamura, and L. Van Kaer, "Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-Associated insulin resistance, " Proceedings of the National Academy of Sciences, vol. 111, no. 43, pp. E4638-E4647, 2014.
92. B. Schiemann, J. L. Gommerman, K. Vora et al., "An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway, " Science, vol. 293, no. 5537, pp. 2111-2114, 2001.
93. M. Hamada, M. Abe, T. Miyake et al., "B cell-Activating factor controls the production of adipokines and induces insulin resistance, " Obesity, vol. 19, no. 10, pp. 1915-1922, 2011.
94. S. K. Chang, B. K. Arendt, J. R. Darce, X. Wu, and D. F. Jelinek, "A role for BLyS in the activation of innate immune cells, " Blood, vol. 108, no. 8, pp. 2687-2694, 2006.
95. R. M. Zinkernagel and P. C. Doherty, "Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system, " Nature, vol. 248, no. 5450, pp. 701-702, 1974.
96. L. A. Morrison, A. E. Lukacher, V. L. Braciale, and D. P. Fan, "Differences in antigen presentation to MHC class I-And class II-restricted influenza virus-specific cytolytic T lymphocyte clones, " The Journal of Experimental Medicine, vol. 163, no. 4, pp. 903-921, 1986.
97. D. A. Hume, "Macrophages asAPC and the dendritic cellmyth, " Journal of Immunology, vol. 181, no. 9, pp. 5829-5835, 2008.
98. K. W. Cho, D. Morris, J. DelProposto et al., "An MHC IIdependent activation loop between adipose tissuemacrophages and CD4+ T cells controls obesity-induced inflammation, " Cell Reports, vol. 9, no. 2, pp. 605-617, 2014.
99. L. Groop and F. Pociot, "Genetics of diabetes-Are we missing the genes or the disease?"Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 726-739, 2014.
100. N. Kato, "Insights into the genetic basis of type 2 diabetes, " Journal of Diabetes Investigation, vol. 4, no. 3, pp. 233-244, 2013.
101. K. Kodama, M. Horikoshi, K. Toda et al., "Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 18, pp. 7049-7054, 2012.
102. J. Zhong, X. Rao, Z. Braunstein et al., "T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance, " Diabetes, vol. 63, no. 4, pp. 1289-1302, 2014.
103. D. Wolf, F. Jehle, N. A. Michel et al., "Coinhibitory suppression ofTcell activation byCD40 protects against obesity and adipose tissue inflammation in mice, " Circulation, vol. 129, no. 23, pp. 2414-2425, 2014.
104. Z. Yi, L. L. Stunz, and G. A. Bishop, "CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment, " Diabetes, vol. 63, no. 8, pp. 2751-2760, 2014.
105. A. Chatzigeorgiou, K. Chung, R. Garcia-Martin et al., "Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation, " Hepatology, vol. 60, no. 4, pp. 1196-1210, 2014.
106. P. S. Linsley, P. M. Wallace, J. Johnson et al., "Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule, " Science, vol. 257, no. 5071, pp. 792-795, 1992.
107. M. Fujii, T. Inoguchi, B. Batchuluun et al., "CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues, " Biochemical and Biophysical Research Communications, vol. 438, no. 1, pp. 103-109, 2013.
108. V. N. Montes, M. S. Turner, S. Subramanian et al., "T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice, " PLoS ONE, vol. 8, no. 7, Article ID e67709, 2013.
109. U. Schonbeck and P. Libby, "The CD40/CD154 receptor/lig and dyad, " Cellular and Molecular Life Sciences, vol. 58, no. 1, pp. 4-43, 2001.
110. C.-A. Guo, S. Kogan, S. U. Amano et al., "CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 304, no. 9, pp. E951-E963, 2013.
111. A. Chatzigeorgiou, T. Seijkens, B. Zarzycka et al., "Blocking CD40-TRAF6 signaling is a therapeutic target in obesityassociated insulin resistance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 7, pp. 2686-2691, 2014.
112. M. Poggi, D. Engel, A. Christ et al., "CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 10, pp. 2251-2260, 2011.
113. D. Wolf, F. Jehle, A. O. Rodriguez et al., "CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-Antibodies, " PLoSONE, vol. 7, no. 3, Article IDe33026, 2012.
114. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia, "Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, " Nature, vol. 401, no. 6754, pp. 708-712, 1999.
115. S. Ariotti, J. B. Beltman, G. Chodaczek et al., "Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 48, pp. 19739-19744, 2012.
116. H. Yang, Y.-H. Youm, B. V and anmagsar et al., "Obesity accelerates thymic aging, " Blood, vol. 114, no. 18, pp. 3803-3812, 2009.
117. S. H. Khan, E. A. Hemann, K. L. Legge, L. A. Norian, and V. P. Badovinac, "Diet-induced obesity does not impact the generation and maintenance of primary memory CD8 T cells, " The Journal of Immunology, vol. 193, no. 12, pp. 5873-5882, 2014.
118. L. F. Su, B. A. Kidd, A. Han, J. J. Kotzin, and M. M. Davis, "Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults, " Immunity, vol. 38, no. 2, pp. 373-383, 2013.
119. E. W. Newell and M. M. Davis, "Beyond model antigens: highdimensional methods for the analysis of antigen-specific T cells, " Nature Biotechnology, vol. 32, no. 2, pp. 149-157, 2014.
120. D. Kolodin, N. van Panhuys, C. Li et al., "Antigen-And cytokinedriven accumulation of regulatory T cells in visceral adipose tissue of lean mice, " Cell Metabolism, vol. 21, no. 4, pp. 543-557, 2015.
121. T. Okada, M. J. Miller, I. Parker et al., "Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells, " PLoS Biology, vol. 3, no. 6, article e150, 2005.
122. B. A. Malynn, D.T. Romeo, and H. H. Wortis, "Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation, " Journal of Immunology, vol. 135, no. 2, pp. 980-988, 1985.
123. T. Kurosaki, H. Shinohara, and Y. Baba, "B cell signaling and fate decision, " Annual Review of Immunology, vol. 28, no. 1, pp. 21-55, 2010.
124. J. L. Scholz, J. E. Crowley, M. M. Tomayko et al., "BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15517-15522, 2008.
125. D. J. DiLillo, Y. Hamaguchi, Y. Ueda et al., "Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice, " Journal of Immunology, vol. 180, no. 1, pp. 361-371, 2008.
126. S. Winer, H. Tsui, A. Lau et al., "Autoimmune islet destruction in spontaneous type 1 diabetes is not -cell exclusive, " Nature Medicine, vol. 9, no. 2, pp. 198-205, 2003.
127. T. Tuomi, N. Santoro, S. Caprio, M. Cai, J. Weng, and L. Groop, "The many faces of diabetes: a disease with increasing heterogeneity, " The Lancet, vol. 383, no. 9922, pp. 1084-1094, 2014.
128. B. M. Brooks-Worrell, J. L. Reichow, A. Goel, H. Ismail, and J. P. Palmer, "Identification of autoantibody-negative autoimmune type 2 diabetic patients, " Diabetes Care, vol. 34, no. 1, pp. 168-173, 2011.
129. P. Almgren, M. Lehtovirta, B. Isomaa et al., "Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study, " Diabetologia, vol. 54, no. 11, pp. 2811-2819, 2011.
130. J. M. Wenzlau, K. Juhl, L. Yu et al., "Thecation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040-17045, 2007.
131. S. Rafiq, D. Melzer, M. N. Weedon et al., "Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes, " Diabetologia, vol. 51, no. 12, pp. 2205-2213, 2008.
132. K. Kodama, K. Toda, S. Morinaga, S. Yamada, and A. J. Butte, "Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice, " Diabetes, vol. 64, no. 3, pp. 867-875, 2015.
133. R. Chen, G. I. Mias, J. Li-Pook-Than et al., "Personal omics profiling reveals dynamic molecular and medical phenotypes, " Cell, vol. 148, no. 6, pp. 1293-1307, 2012.
134. F. H. Karlsson, V. Tremaroli, I. Nookaew et al., "Gut metagenome in European women with normal, impaired and diabetic glucose control, " Nature, vol. 498, no. 7452, pp. 99-103, 2013.
135. S. Rabot, M. Membrez, A. Bruneau et al., "Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism, " The FASEB Journal, vol. 24, no. 12, pp. 4948-4959, 2010.
136. P. D. Cani, R. Bibiloni, C. Knauf et al., "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, " Diabetes, vol. 57, no. 6, pp. 1470-1481, 2008.
137. R. Caesar, C. S. Reigstad, H. K. Bäckhed et al., "Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice, " Gut, vol. 61, no. 12, pp. 1701-1707, 2012.
138. Y. Wang, J. Li, L. Tang et al., "T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding, " PLoS ONE, vol. 5, no. 11, Article ID e13951, 2010.
139. S. R. Kashyap, E. S. Louis, and J. P. Kirwan, "Weight loss as a cure for Type 2 diabetes: fact or fantasy?" Expert Review of Endocrinology& Metabolism, vol. 6, no. 4, pp. 557-561, 2011.
140. A. P. Courcoulas, B. H. Goodpaster, J. K. Eagleton et al., "Surgical vs medical treatments for type 2 diabetes mellitus: a r and omized clinical trial, " JAMA Surgery, vol. 149, no. 7, p. 707, 2014.
141. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, "C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, " Journal of the American Medical Association, vol. 286, no. 3, pp. 327-334, 2001.
142. A. Han, J. Glanville, L. Hansmann, and M. M. Davis, "Linking T-cell receptor sequence to functional phenotype at the singlecell level, " Nature Biotechnology, vol. 32, no. 7, pp. 684-692, 2014.
143. B. J. Dekosky, G. C. Ippolito, R. P. Deschner et al., "Highthroughput sequencing of the paired human immunoglobulin heavy and light chain repertoire, " Nature Biotechnology, vol. 31, no. 2, pp. 166-169, 2013.
144. M. E. Birnbaum, J. L. Mendoza, D. K. Sethi et al., "Deconstructing the peptide-MHC specificity of T cell recognition, " Cell, vol. 157, no. 5, pp. 1073-1087, 2014.
145. J. V. Price, S. Tangsombatvisit, G. Xu et al., "On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions, " Nature Medicine, vol. 18, no. 9, pp. 1434-1440, 2012.